Latest Breaking News On - Huck institutes of life sciences - Page 1 : comparemela.com

Researchers develop digital test to directly measure HIV viral load

Researchers develop digital test to directly measure HIV viral load
sciencedaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from sciencedaily.com Daily Mail and Mail on Sunday newspapers.

Anthonyj politzaReza nouriWeihua guanTianyi liJonathanj nunezYusheng zhuYuqian jiangWallaceh greeneNational institutes of healthHuck institutes of life sciencesDepartment of medicinePenn state college of medicinePenn state college of engineeringNational science foundationDepartment of pathologyPenn state

Penn State researchers develop digital test to directly measure HIV viral load

Penn State researchers develop digital test to directly measure HIV viral load
psu.edu - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from psu.edu Daily Mail and Mail on Sunday newspapers.

Yuqian jiangYusheng zhuReza nouriWeihua guanJonathanj nunezWallaceh greeneAnthonyj politzaTianyi liNational institutes of healthPenn state college of medicineDepartment of pathologyPenn state college of engineeringHuck institutes of life sciencesDepartment of medicineNational science foundationPenn state

T-cell vaccine for COVID-19 may last longer than current vaccines

The current COVID-19 vaccines are designed to trigger an antibody response to the SARS-CoV-2 spike protein, which is vulnerable to mutations that could make the vaccine less effective over time. Focusing on the T-cell instead, Penn State researchers partnered with Evaxion Biotech on a study that was the first to demonstrate the effectiveness of an artificial intelligence-generated vaccine in a live viral challenge model. Such a vaccine may provide long-lasting immunity against future emerging variants and could be used as a model for other seasonal viral diseases like the flu.

Michael schantz klausenBhuvana katkereJulie hinchelli emdrupSophie schussekMckayla nicolKatherine restoriAnders bundgaardGirish kirimanjeswaraEvaj pell laboratoryHuck institutes of life sciencesCenters for diseaseNational institutes of healthInnovation fund denmarkCollege of agricultural sciencesPenn stateEvaxion biotech

T-Cell COVID-19 Vaccine Offers Longer Protection Than Current Vaccines

T-Cell COVID-19 Vaccine Offers Longer Protection Than Current Vaccines
miragenews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from miragenews.com Daily Mail and Mail on Sunday newspapers.

Anders bundgaardMichael schantz klausenMckayla nicolJulie hinchelli emdrupGirish kirimanjeswaraBhuvana katkereKatherine restoriSophie schussekHuck institutes of life sciencesCollege of agricultural sciencesNational institutes of healthCenters for diseaseInnovation fund denmarkEvaj pell laboratoryPenn stateEvaxion biotech

T-cell vaccine for COVID-19 may last longer t

The current COVID-19 vaccines are designed to trigger an antibody response to the SARS-CoV-2 spike protein, which is vulnerable to mutations that could make the vaccine less effective over time. Focusing on the T-cell instead, Penn State researchers partnered with Evaxion Biotech on a study that was the first to demonstrate the effectiveness of an artificial intelligence-generated vaccine in a live viral challenge model. Such a vaccine may provide long-lasting immunity against future emerging variants and could be used as a model for other seasonal viral diseases like the flu.

Bhuvana katkereMichael schantz klausenMckayla nicolGirish kirimanjeswaraJulie hinchelli emdrupKatherine restoriSophie schussekAnders bundgaardInnovation fund denmarkCollege of agricultural sciencesCenters for diseaseHuck institutes of life sciencesNational institutes of healthEvaj pell laboratoryPenn stateEvaxion biotech